Cargando…

Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer

AIMS: Device replacement at the time of battery depletion of implantable cardioverter-defibrillators (ICDs) may carry a considerable risk of complications and engenders costs for healthcare systems. Therefore, ICD device longevity is extremely important both from a clinical and economic standpoint....

Descripción completa

Detalles Bibliográficos
Autores principales:	Landolina, Maurizio, Curnis, Antonio, Morani, Giovanni, Vado, Antonello, Ammendola, Ernesto, D'onofrio, Antonio, Stabile, Giuseppe, Crosato, Martino, Petracci, Barbara, Ceriotti, Carlo, Bontempi, Luca, Morosato, Martina, Ballari, Gian Paolo, Gasparini, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	CLINICAL RESEARCH
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535557/ https://www.ncbi.nlm.nih.gov/pubmed/25976906 http://dx.doi.org/10.1093/europace/euv109

Ejemplares similares

The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives
por: Landolina, Maurizio, et al.
Publicado: (2017)

The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
por: Botto, Giovanni Luca, et al.
Publicado: (2017)

Favorable Trend of Implantable Cardioverter‐Defibrillator Service Life in a Large Single‐Nation Population: Insights From 10‐Year Analysis of the Italian Implantable Cardioverter‐Defibrillator Registry
por: Poli, Stefano, et al.
Publicado: (2019)

Cost‐minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications
por: Boriani, Giuseppe, et al.
Publicado: (2021)

Use of a novel implantable cardioverter‐defibrillator multisensor algorithm for heart failure monitoring in a COVID‐19 patient: A case report
por: Bontempi, Luca, et al.
Publicado: (2021)

Manual vs. automatic capture management in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators
por: Murgatroyd, Francis D., et al.
Publicado: (2010)

Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation
por: Rapacciuolo, Antonio, et al.
Publicado: (2021)

Cost-Utility Analysis of the EVOLVO Study on Remote Monitoring for Heart Failure Patients With Implantable Defibrillators: Randomized Controlled Trial
por: Zanaboni, Paolo, et al.
Publicado: (2013)

Watchful Waiting in an Unusual Cause of Hypoxemia after Implantable Cardioverter-Defibrillator Lead Extraction
por: Bejko, Jonida, et al.
Publicado: (2019)

Loss of cardiac resynchronization therapy in a patient with a biventricular implantable cardioverter-defibrillator
por: Alasti, Mohammad, et al.
Publicado: (2017)

Economic analysis of remote monitoring in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators in the Trento area, Italy
por: Marini, Massimiliano, et al.
Publicado: (2023)

The economic impact of remote control in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators: single center experience
por: Marini, M, et al.
Publicado: (2023)

Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time
por: von Gunten, Simon, et al.
Publicado: (2016)

Design of the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study to assess the ability of remote monitoring to treat and triage patients more effectively
por: Marzegalli, Maurizio, et al.
Publicado: (2009)

Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Foo, Fang Shawn, et al.
Publicado: (2019)

Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy
por: Jing, Ran, et al.
Publicado: (2020)

Implantable Cardioverter Defibrillator Multisensor Monitoring during Home Confinement Caused by the COVID-19 Pandemic
por: Ziacchi, Matteo, et al.
Publicado: (2022)

The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems
por: Elliott, Mark K., et al.
Publicado: (2021)

One Indication for an Extravascular Cardiac Resynchronization Therapy Defibrillator: Lessons from a Combination Therapy Case with Epicardial Cardiac Resynchronization Therapy and a Subcutaneous Implantable Cardioverter Defibrillator
por: Ishii, Natsuko, et al.
Publicado: (2021)

Implantation of a Resynchronization Implantable Cardioverter Defibrillator in a Patient with Persistent Left Superior Vena Cava
por: Antonelli, Dante, et al.
Publicado: (2007)

Editorial to implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS‐QI 33)
por: Minamiguchi, Hitoshi
Publicado: (2019)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Effects of COVID‐19 lockdown on arrhythmias in patients with implantable cardioverter‐defibrillators in southern Italy
por: Ducceschi, Valentino, et al.
Publicado: (2022)

Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice
por: Calò, Leonardo, et al.
Publicado: (2021)

Inappropriate Shock Delivered By Implantable Cardioverter Defibrillator - Cardiac Resynchronization Therapy (ICD-CRT) Due To Myopotential Oversensing
por: Barakpour, Hamid, et al.
Publicado: (2009)

A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure
por: Tomini, F., et al.
Publicado: (2016)

Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?
por: Braunschweig, Frieder, et al.
Publicado: (2019)

Efficacy and Safety of Transvenous Lead Extraction at the Time of Upgrade from Pacemakers to Cardioverter-Defibrillators and Cardiac Resynchronization Therapy
por: Stefańczyk, Paweł, et al.
Publicado: (2022)

The Interplay of PR Interval and AV Pacing Delays Used for Cardiac Resynchronization Therapy in Heart Failure Patients: Association with Clinical Response in a Retrospective Analysis of a Large Observational Study
por: Gasparini, Maurizio, et al.
Publicado: (2022)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of a biventricular implantable cardioverter-defibrillator guided by an electroanatomic mapping system
por: Del Greco, Maurizio, et al.
Publicado: (2012)

Procedure, management, and outcome of subcutaneous implantable cardioverter–defibrillator extraction in clinical practice
por: De Filippo, Paolo, et al.
Publicado: (2023)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Importance of Implantable Cardioverter‐Defibrillator Back‐Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta‐Analysis
por: Barra, Sérgio, et al.
Publicado: (2015)

Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators
por: Kawamura, Mitsuharu, et al.
Publicado: (2019)

Premature ventricular contractions in patients with an implantable cardioverter defibrillator cardiac resynchronization therapy device: Results from the UMBRELLA registry
por: Akerström, Finn, et al.
Publicado: (2020)

Cost-effectiveness of cardiac resynchronization therapy plus an implantable cardioverter-defibrillator in patients with heart failure: a systematic review
por: Teimourizad, Abedin, et al.
Publicado: (2021)

Bridge to avoid ICD implantation with wearable cardioverter defibrillators
por: Zoppo, Franco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mufbh1b6qqerpt3i82c7jj49q6